Publications by authors named "Sverre Erik Kjeldsen"

Objective: Available data on the association between antihypertensive drugs and cancer are characterized by a few years follow-up. Our aim has been to evaluate the association between long-term exposure to antihypertensive drugs and the risk of cancer occurrence.

Methods: Using the healthcare utilization databases of the Lombardy region (Italy), individuals aged 40-85 years who had no previous history of cancer and were newly dispensed with at least one antihypertensive drug from the major drug classes between 2009 and 2011 were followed from the first drug dispensation to December 31, 2020.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic kidney disease (CKD) is a major complication for people with diabetes, making it crucial to monitor kidney health in these patients.
  • Recent studies identify various drugs that offer protection for the kidneys, potentially improving outcomes for diabetic patients.
  • The article discusses markers for tracking kidney disease progression and highlights new treatment options available for managing CKD in diabetic patients.
View Article and Find Full Text PDF

Background: Elevations of creatine kinase-MB (CK-MB) and cardiac troponin T (cTnT) have an uncertain long-term prognostic value after coronary artery bypass graft (CABG) surgery. We aimed to test the hypothesis that CK-MB and cTnT are predictors of long-term survival after CABG and to assess which of these 2 biomarkers is the better predictor.

Methods: A total of 1,350 consecutive patients undergoing isolated on-pump CABG had CK-MB and cTnT measured at 7, 20, and 44 hours, postoperatively.

View Article and Find Full Text PDF
Article Synopsis
  • * Even when high-risk individuals are identified, they may not receive all available treatment options or may not stick to their prescribed treatment plans.
  • * The goal is to improve management of these high-risk patients by following existing guidelines and evidence-based practices, which should lead to better health outcomes.
View Article and Find Full Text PDF

Aims: We have previously found improved insulin sensitivity in hypertensives after additional treatment with angiotensin II-receptor blocker (ARB) compared with calcium-channel blocker (CCB) alone, despite similar blood pressure lowering effects. In this study, we compare the effect of these two principal different vasodilating agents on the autonomic nervous system in the same patients, and test whether potential differences in these variables might explain the difference seen in insulin sensitivity.

Methods: In a double-blind crossover study, 21 hypertensive patients were randomized to receive either 100 mg losartan (ARB) or 5 mg amlodipine (CCB) in addition to an open-labelled treatment of amlodipine 5 mg.

View Article and Find Full Text PDF

Hypertension and diabetes mellitus (DM) are known risk factors for atrial fibrillation (AF). We investigated the influence of new-onset DM on developing AF in the VALUE trial population of high-risk hypertensive patients. Five thousand two hundred fifty patients of the 15,245 participants in the VALUE trial had DM at baseline and 1,298 of the initially nondiabetic patients developed DM during the average 4.

View Article and Find Full Text PDF

Hypertension is a high-prevalence disease that may affect several organs. In recent years, data have accumulated indicating that angiotensin II receptor blockers (ARBs) may have a supplementary effect beyond lowering blood pressure. The aim of this review is to evaluate the impact of ARBs on the most important complications of hypertension--heart, cerebrovascular and renal diseases, and metabolic complications--based on the findings from large clinical hypertension trials.

View Article and Find Full Text PDF

Endothelial dysfunction is reflected by an impaired nitric oxide (NO)-mediated vasodilatation. Insulin resistance may be linked to endothelial dysfunction by several mechanisms, including disturbances in signaling pathways common to both insulin action and NO production. Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, may contribute to endothelial dysfunction, and elevated ADMA levels have been associated with both insulin levels and the degree of insulin resistance.

View Article and Find Full Text PDF

Background: Possible mechanisms behind psychophysiological hyperreactivity may be located at a cognitive-emotional level. Several personality traits have been associated with increased cardiovascular reactivity. Subjects with white coat hypertension, which may constitute a kind of hyperreactivity, are found to suppress their emotions and adapt to the surroundings to a larger extent than controls.

View Article and Find Full Text PDF
Article Synopsis
  • Recent hypertension trials reveal varying impacts on new-onset diabetes mellitus depending on the type of antihypertensive medication used, with thiazide diuretics and beta-blockers linked to unchanged or increased incidence, while ACE inhibitors and calcium channel blockers suggest a decrease or no change.
  • The ASCOT trial indicated that the combination of calcium channel blockers and ACE inhibitors is more effective than the traditional mix of beta-blockers and diuretics.
  • The review discusses these findings and considers how different drug regimens may influence glucose control, highlighting the need to rethink antihypertensive treatment choices while emphasizing that the primary goal remains to effectively lower blood pressure, often requiring multiple medications.
View Article and Find Full Text PDF

Background: N-terminal pro-B-type natriuretic peptide (NT-proBNP) appears to be a strong risk marker of mortality in patients with acute coronary syndrome. However, little information is available on NT-proBNP as a predictor of long-term serious cardiovascular events beyond that of left ventricular ejection fraction in patients with acute myocardial infarction (AMI), most of them treated with an early invasive strategy and on a uniform optimal secondary preventive medication including long-term beta-adrenergic receptor blockade.

Objective: To assess the prognostic impact of plasma NT-proBNP in patients with AMI who received optimal medical treatment including long-term beta-adrenergic receptor blockade.

View Article and Find Full Text PDF
Article Synopsis
  • Beta-blockers like carvedilol and atenolol are commonly used to improve outcomes for patients after a heart attack, but their effects on heart function may vary.
  • In a study with 232 patients, both medications were tested for their impact on left ventricular ejection fraction (LVEF) and cardiovascular events over 12 months.
  • The results showed no significant difference in heart function between the two drugs, but carvedilol was associated with fewer serious cardiovascular events and less frequent cold extremities.
View Article and Find Full Text PDF